Ra. Radcliffe et Vg. Erwin, GENETIC-RELATIONSHIP BETWEEN CENTRAL BETA-ENDORPHIN AND NOVELTY-INDUCED LOCOMOTOR-ACTIVITY, Pharmacology, biochemistry and behavior, 60(3), 1998, pp. 709-718
The goal of research presented in this report was to investigate the p
ossibility that differences in beta-ED levels could account far some p
ortion of genetically mediated variation in locomotor activity. Subjec
ts representing six of the LSXSS RI mouse strains were activity tested
in a novel environment. Significant effects of strain and time as wel
l as a significant strain by time interaction were detected. beta-EB l
evels were estimated from several brain regions and the pituitary of n
aive and activity-tested mice. Significant strain effects were detecte
d in all brain regions but not in the pituitary. There was no overall
effect of exposure to novelty, but some strains showed either a decrea
se or an increase in beta-ED levels in the septum, amygdala, and midbr
ain. A significant genetic correlation between adaptation to the novel
environment (locomotor activity at 30 min subtracted from locomotor a
ctivity at 5 min) and beta-ED levels in the septum was observed. Estim
ates of hypothalamic mRNA for the beta-ED precursor POMC revealed no e
ffect of strain. Finally, locomotor activity was tested following dose
s of the mu-opioid antagonist naltrexone. Out of six strains tested (n
aive to the apparatus), naltrexone dose dependently attenuated locomot
or activity in only the strain that showed the highest control level o
f activity. The results suggest that beta-ED levels influence novelty-
induced locomotor activity, but that other important genotype-dependen
t factors are involved. (C) 1998 Elsevier Science Inc.